WHO data show 8.2 million people were newly diagnosed with TB in 2023, up from 7.5 million in 2022 and the highest number recorded since 1995.
At 132 weeks from randomization, two bedaquiline-containing regimens maintained superiority compared with a 9-month injectable-based regimen.
Researchers found a 43% drop in DR-TB case notifications in a South African province after COVID-19 lockdowns were implemented.
The company has agreed to withdraw a secondary patent on the drug, which will allow generic suppliers to produce lower-cost versions.
Eli Lilly says it will use OpenAI's generative AI to discover novel new antimicrobials.
Data show US TB programs have made strides in identifying patients with TB and latent TB infection and in ensuring they complete treatment in a timely manner.
The estimated fatality rate among hospitalized patients with TB-COVID co-infection was 11%.
The investigation revealed that 170 people—many of them in high-risk groups—may have been exposed to TB, a number expected to grow.
Four participants in the study developed early TB disease, all of whom were severely malnourished.
Researchers estimate that 85 pathogens accounted for 704 million disability-adjusted life years globally in 2019.
